Pfizer’s XELJANZ website ecosystem was fragmented across multiple subdomains, resulting in a disjointed experience for patients, caregivers, and healthcare professionals. My challenge was to lead a full redesign and consolidation effort that delivered a modern, user-centered, and compliant masterbrand site for XELJANZ—aligning business needs with regulatory processes and improved usability.
The XELJANZ web experience was spread across three separate sites, each targeting different audiences with overlapping or duplicated content. This approach led to:
By unifying the XELJANZ experience under a single masterbrand framework, we were able to:
As Design Director, I owned the full end-to-end experience:
We combined user research and analytics to understand pain points and identify high-value user pathways—specifically targeting increased CRM registration rates, our core KPI.
Users mistrusted the objectivity of content. We improved content strategy and navigation to give users more direct access to what mattered most to them.
Overly long and complex forms were hurting conversions. We streamlined the experience into dynamic, multi-step forms that responded to user inputs in real-time.
We defined a clear content hierarchy and refined the user journey across all pages. Key improvements included:
Using brand guidelines and research-backed wireframes, we explored multiple visual directions for key pages:
This project marked a major shift from static design tools like Photoshop to more collaborative tools like Sketch and Abstract. To support this transition, I:
The launch was a transformative milestone, replacing a 5-year-old legacy experience with a scalable, user-centered platform. Notable outcomes:
Like any digital product, the work didn’t stop at launch. Before my departure, I helped establish a roadmap for continued evolution of the XELJANZ digital experience. Key areas of focus included:
These recommendations laid the groundwork for the team to continue evolving the platform with a user-centered, scalable mindset.